Raloxifene Hydrochloride Tablet, Coated
Product Images NDC 72241-010

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 72241-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Modavar Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Modavar-cont-label-60mg-100-tab (Modavar Cont Label 60mg 100 Tab)

Packaging label for Raloxifene Hydrochloride Tablets, USP 60 mg, coated tablets, oral use. The label indicates the product is manufactured by Cadila Pharmaceuticals Ltd. and labeled by Modavar Pharmaceuticals LLC. It includes storage instructions, usual dosage directions, and a barcode. Package contains 100 tablets and is Rx only.*

FDA Label Image

Modavar-cont-label-60mg-1000-tab (Modavar Cont Label 60mg 1000 Tab)

Label for Raloxifene Hydrochloride Tablets, USP, 60 mg coated tablets by Modavar Pharmaceuticals LLC. The label indicates a package size of 1000 tablets and includes storage instructions and manufacturing details for Cadila Pharmaceuticals Ltd. and Modavar Pharmaceuticals LLC. The label features the NDC 72241-010-11 and states 'Rx only.'*

FDA Label Image

Modavar-cont-label-60mg-2000-tab (Modavar Cont Label 60mg 2000 Tab)

Label for Raloxifene Hydrochloride Tablets, USP 60 mg, oral coated tablets by Modavar Pharmaceuticals LLC. The label indicates the product is prescription only with a total of 2000 tablets. Manufacturer details include Cadila Pharmaceuticals Ltd., India, and Modavar Pharmaceuticals LLC, Washington, DC. Storage instructions and a caution about dispensing in child-resistant containers are also present.*

FDA Label Image

Modavar-cont-label-60mg-30-tab (Modavar Cont Label 60mg 30 Tab)

Label for Raloxifene Hydrochloride Tablets, USP 60 mg, coated oral tablets, in a 30-tablet package. Manufactured by Cadila Pharmaceuticals Ltd. and labeled by Modavar Pharmaceuticals LLC. The label includes storage instructions, dosage advisory, barcode, and lot information with an orange highlight for the strength.*

FDA Label Image

Raloxifene-spl-figure-1 (Raloxifene Spl Figure 1)

Two line graphs displaying total hip mean percentage change from baseline over 24 months among placebo and Raloxifene Hydrochloride subjects. The first graph shows data from North America and Europe studies; the second adds a conjugated estrogens group from a study on hysterectomized women. Both show percentage change on the y-axis and months after randomization on the x-axis.*

FDA Label Image

Raloxifene-spl-strc.jpg (Raloxifene Spl Strc)

Chemical structure diagram of raloxifene hydrochloride showing its molecular framework with various rings, hydroxyl groups, and a hydrochloride ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.